Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we will assume that you are happy to receive all cookies and you will not see this message again. Click 'Find out more' for information on how to change your cookie settings.

OPDC researchers have developed a new genetic mouse model of Parkinson's to track the earliest changes that take place in the brain.

The knowledge gained from their groundbreaking study, published in the leading scientific journal PNAS, could pave the way for new treatments that can slow or stop Parkinson's in its tracks. This study is the first to show that the way the chemical messenger dopamine is stored and released is affected at the very start of the process – before Lewy bodies appear.

Read the press release: http://www.parkinsons.org.uk/news/3-october-2013/clues-about-early-stages-parkinsons-new-mouse-model